Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viral Meningitis01:18

Viral Meningitis

219
Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
219
Arboviral Encephalitis01:25

Arboviral Encephalitis

70
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
70
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

32
Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
32
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

29
Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
29
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

32
Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
32
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

28
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human Research Protections during Emergencies: An Integrative Review.

Ethics & human research·2026
Same author

Participatory Approaches to Risk Assessment Across One Health Disciplines: A Scoping Review.

Health security·2026
Same author

Ethical Preparedness for U.S. Biocontainment Units.

Journal of bioethical inquiry·2026
Same author

Linking Disaster Predictions to Health Care Strain and Costs: A Novel Military-Civilian Case Study.

Disaster medicine and public health preparedness·2026
Same author

Long-Range Air Transportation for High-Consequence Infectious Diseases: Findings from a Global Tabletop Exercise on Patients with Viral Hemorrhagic Fever.

Prehospital emergency care·2025
Same author

Preparedness and Response Considerations for High-Consequence Infectious Disease.

Emerging infectious diseases·2025

Related Experiment Video

Updated: May 8, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

21.5K

Nipah virus: a summary for clinicians.

Corri B Levine1, Lauren M Sauer2, Susan L F McLellan1

  • 1University of Texas Medical Branch, Galveston, TX, 77555, USA.

International Journal of Emergency Medicine
|July 9, 2025
PubMed
Summary

Nipah virus (NiV) infection lacks approved treatments, but two U.S. FDA-approved antivirals show potential. Multiple NiV vaccines are in pre-clinical development, offering hope for future prevention and treatment strategies.

More Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.2K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.7K

Related Experiment Videos

Last Updated: May 8, 2026

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
12:20

Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses

Published on: December 29, 2015

21.5K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.2K
A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.7K

Area of Science:

  • Emerging infectious diseases
  • Viral pathogenesis
  • Medical countermeasures

Background:

  • Nipah virus (NiV) is a significant emerging pathogen with pandemic potential.
  • Limited human clinical data exists for NiV due to infrequent outbreaks.
  • Understanding NiV clinical perspectives is crucial for developing effective responses.

Purpose of the Study:

  • To provide a global overview of clinical perspectives on Nipah virus.
  • To summarize pathogenesis, clinical features, and diagnostics of NiV infection.
  • To highlight potential therapies and vaccines for NiV, aiding clinical decision-making.

Main Methods:

  • Literature review focused on NiV vaccines and therapeutics.
  • Evaluation of treatments tested in animal models of NiV disease.

Main Results:

  • Two U.S. FDA-approved antiviral medications identified for potential off-label NiV treatment.
  • Numerous other antiviral candidates are in early-stage development.
  • Multiple NiV vaccine platforms are in pre-clinical stages, with human trial data pending.

Conclusions:

  • This review offers clinicians a rapid reference for NiV background, manifestations, and countermeasures.
  • Identified medical countermeasures provide candidates for emergency use and clinical research.
  • The findings support further investigation into NiV therapies and vaccines for outbreak settings.